期刊文献+

谷赖胰岛素不同注射方式治疗对2型糖尿病患者围术期血糖控制的有效性和安全性 被引量:5

Effectiveness and safety of insulin glulisine therapy with different injection methods for perioperative blood glucose control in patients with type 2 diabetes
下载PDF
导出
摘要 目的探讨谷赖胰岛素不同注射方式治疗对2型糖尿病患者围术期血糖控制的有效性和安全性。方法将141例2型糖尿病患者随机分为3组,分别给予皮下注射谷赖胰岛素(SII-G)治疗(SII-G组,n=48),胰岛素泵持续输注谷赖胰岛素(CII-G)治疗(CII-G组,n=47)和皮下注射赖脯胰岛素(SII-L)治疗(SII-L组,n=46)。比较3组患者血糖控制稳定所用时间、住院时间、每日胰岛素用量、住院总费用、术后感染及低血糖发生情况。结果 CII-G组每日胰岛素用量均少于SII-G组和SII-L组(均P<0.05),而SII-G组和SII-L组每日胰岛素用量无统计学差异(P>0.05);SII-L组血糖控制稳定时间、住院时间及住院总费用均长于或多于CII-G组和SII-G组(均P<0.05),而CII-G组和SII-G组血糖控制稳定时间、住院时间及住院总费用无明显差异(均P>0.05)。3组围术期低血糖发生率及术后感染发生率比较,差异均无统计学意义(均P>0.05)。结论糖尿病患者围术期采用谷赖胰岛素不同注射方式进行降糖治疗均安全、有效,效果均较赖脯胰岛素更好,而采用CII-G可减少每日胰岛素用量。 Objective To explore the effectiveness and safety of insulin glulisine therapy with different injection methods for perioperative blood glucose control in the patients with type 2 diabetes.Methods A total of 141 patients with type 2 diabetes were randomly assigned into three groups,then subcutaneous injection of insulin glulisine(SII-G),continuous injection of insulin glulisine by insulin pump(CII-G) and subcutaneous injection of insulin lispro(SII-L) were conducted in SII-G group(n=48),CII-G group(n=47) and SII-L group(n=46) respectively.The duration for blood glucose stabilization,hospital stay,daily dose of insulin,total expense of hospitalization,incidence of postoperative infection and hypoglycemia were compared between the three groups.Results The daily dose of insulin in the CII-G group was less than that in the SII-G group or SII-L group(all P<0.05),whereas no statistically significant difference in the daily dose of insulin was found between the SII-G group and SII-L group(P>0.05);the duration for blood glucose stabilization,hospital stay,and total hospitalization expense of the SII-L group were longer or more than those of the CII-G group or SII-G group(all P<0.05),while no statistically significant differences in the above mentioned indicators were found between the CII-G group and SII-G group(all P>0.05).There were no statistically significant differences in the incidence rates of perioperative hypoglycemia and postoperative infection between the three groups(all P>0.05).Conclusion Employing insulin glulisine with different injection methods to perioperative hypoglycemic therapy is safe and effective in the diabetic patients,and can obtain a better effect as compared with insulin lispro,and administration of CII-G can reduce the daily dose of insulin.
作者 叶盛开 任霞 陈海英 YE Sheng-kai;REN Xia;CHEN Hai-ying(Department of Endocrinology,the 967th Hospital of Joint Logistic support force of Chinese People′s Liberation Army,Dalian 116021,China)
出处 《广西医学》 CAS 2019年第21期2681-2684,共4页 Guangxi Medical Journal
基金 国家自然科学基金(31730041) 辽宁省大连市医学科学研究计划项目(1812049)
关键词 2型糖尿病 谷赖胰岛素 赖脯胰岛素 围术期 血糖 注射方式 Type 2 diabetes Insulin glulisine Insulin lispro Perioperation Blood glucose Injection method
  • 相关文献

参考文献8

二级参考文献89

  • 1吴波,韩萍,刘秀华.胰岛素泵在糖尿病病人围手术期的临床应用[J].中国医科大学学报,2005,34(1):87-88. 被引量:6
  • 2American Diabehes Association.Implications of the diabetes control and complications trias[J].Diabetes Care,2000,23(Suppl 1):524-526.
  • 3World Health Organization. Diabetes Mellitus. Facts sheet 2006, number 316. Available from: http://www.who.int/mediacentre/ factsheets/fs312/en/.
  • 4Yang WY, Lu JM, Weng JP, et al. Prevalence of Diabetes among Men and Women in China[J]. N Eng 1J Med, 2010, 362(12): 1090-1101.
  • 5The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J]. N Engl J Med, 1993,329(14): 977-986.
  • 6UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet, 1998, 352(9131): 837-853.
  • 7Home P. Contributions of basal and post-prandial hyperglycaemia to micro and macrovascular complications in people with type 2 diabetes [J]. Curr Med Res Opin, 2005, 21(7): 989-998.
  • 8Leiter LA, Ceriello A, Davidson JA, et al. Post-prandial glucose regulation: new data and new implications[J]. Clin Ther, 2005, 27(Suppl 2): S42-S56.
  • 9Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a con-sensus statement from the American diabetes Association and the European Association for theStudy of Diabetes [J]. Diabetes Care, 2006, 29(8): 1963-1972.
  • 10Becker RH. Insulin glulisine complementing basal insulins: a review of structure and activity [J]. Diabetes Technol Ther, 2007, 9( 1):109-2 l.

共引文献197

同被引文献54

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部